Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
Immunoassay/Chemical Analyzer and Reagents is a federal award for Fa4690 28 Cons Pkc held by Ortho-Clinical Diagnostics, Inc. Estimated value $755K ($597K obligated). Current period of performance ends Feb 22, 2027. Last award drew 3 bidders. Place of performance: RARITAN NJ.
Immunoassay/chemical analyzer and reagents. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Feb 22, 2027 (128 days remaining). Agencies typically plan 12–18 months ahead — at 4.2 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on FA469022F0018? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordOrtho-Clinical Diagnostics, Inc — $57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract FA469022F0018?
FA469022F0018 (Immunoassay chemical analyzer and reagents) is a Fa4690 28 Cons Pkc award with a potential value of $755K, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is FA4690-22-F-0018?
FA4690-22-F-0018 is the dashed form of PIID FA469022F0018 (Immunoassay chemical analyzer and reagents), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded FA469022F0018?
Fa4690 28 Cons Pkc awarded FA469022F0018 to Ortho-Clinical Diagnostics, Inc (potential $755K).
Who is the incumbent on FA469022F0018?
Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Feb 22, 2027.
When does Ortho-Clinical Diagnostics, Inc’s FA469022F0018 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 22, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on FA469022F0018? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.